You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hemophagocytic lymphohistiocytosis

Showing 1 - 25 of 131
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma-associated Hemophagocytic Lymphohistiocytosis

Recruiting
  • Lymphoma
  • Hemophagocytic Lymphohistiocytoses
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Jun 1, 2023

    EBV-associated Hemophagocytic Lymphohistiocytosis, EBV Infection Trial in Beijing (EBV-TCR-T cells)

    Recruiting
    • EBV-associated Hemophagocytic Lymphohistiocytosis
    • EBV Infection
    • EBV-TCR-T cells
    • Beijing, Beijing, China
      Chinese PLA General Hospital
    Nov 12, 2023

    Refractory, Recurrence, Hemophagocytic Lymphohistiocytosis Trial (GTP regimen)

    Not yet recruiting
    • Refractory
    • +2 more
    • GTP regimen
    • (no location specified)
    Sep 8, 2023

    IFN? and Inflammatory Mediators in Hemophagocytic

    Completed
    • Hemophagocytic Lymphohistiocytoses
    • Blood Draws Data Collection
    • Boston, Massachusetts
      Brigham and Women's Hospital
    Sep 14, 2023

    Carbapenem Resistant Bacterial Infection, Hemophagocytic Lymphohistiocytoses Trial in Beijing (Carrimycin tablets)

    Not yet recruiting
    • Carbapenem Resistant Bacterial Infection
    • Hemophagocytic Lymphohistiocytoses
    • Carrimycin tablets
    • Beijing, Beijing, China
      Beijing Friendship Hospital, Capital Medical University
    Aug 4, 2023

    PD-1 Antibody, Hemophagocytic Lymphohistiocytosis, Epstein-Barr Virus Trial in Beijing (L-DEP and PD-1 antibody)

    Not yet recruiting
    • PD-1 Antibody
    • +3 more
    • L-DEP and PD-1 antibody
    • Beijing, Beijing, China
      Beijing Friendship Hospital, Capital Medical University
    Mar 8, 2023

    Hemophagocytic Lymphohistiocytoses Trial in Cincinnati

    Recruiting
    • Hemophagocytic Lymphohistiocytoses
      • Cincinnati, Ohio
        Cincinnati Children's Hospital Medical Center
      Oct 25, 2022

      Immune Function and PD-1 Antibody Therapy Efficacy Predictors on

      Recruiting
      • Secondary Hemophagocytic Lymphohistiocytosis
      • Chronic Active Epstein-Barr Virus Infection
      • No intervention
      • Beijing, Beijing, China
        Beijing Friendship Hospital, Capital Medical University
      May 2, 2023

      Segmental Resection Combined With DEP Regimen for EBV-HLH

      Not yet recruiting
      • Hemophagocytic Lymphohistiocytosis
      • +2 more
      • Segmental bowel resection combined with the DEP regimen
      • Beijing, Beijing, China
        Zhao Wang
      Nov 9, 2023

      Hemophagocytic Lymphohistiocytosis Trial in Beijing (Venetoclax, Dexamethasone, Etoposide)

      Recruiting
      • Hemophagocytic Lymphohistiocytosis
      • Beijing, Beijing, China
        Beijing Friendship Hospital, Capital Medical University
      Sep 15, 2022

      Secondary Hemophagocytic Lymphohistiocytosis (sHLH) Trial in Worldwide (ELA026)

      Recruiting
      • Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
      • Innsbruck, Austria
      • +9 more
      Oct 24, 2022

      Hemophagocytic Lymphohistiocytosis Trial in Philadelphia (tocilizumab)

      Withdrawn
      • Hemophagocytic Lymphohistiocytosis
      • Philadelphia, Pennsylvania
        Children's Hospital of Philadelphia
      Mar 11, 2022

      Hemophagocytic Lymphohistiocytosis Trial in United States (Ruxolitinib, Dexamethasone, Etoposide)

      Recruiting
      • Hemophagocytic Lymphohistiocytosis
      • Phoenix, Arizona
      • +9 more
      Jan 9, 2023

      Secondary Hemophagocytic Lymphohistiocytosis, Chronic Active Epstein-Barr Virus Infection Trial in Beijing (Rituximab

      Recruiting
      • Secondary Hemophagocytic Lymphohistiocytosis
      • Chronic Active Epstein-Barr Virus Infection
      • Rituximab Monotherapy
      • Beijing, China
        Zhao Wang
      May 18, 2022

      Hemophagocytic Lymphohistiocytoses, Lymphoma Trial in Beijing (cytokine)

      Not yet recruiting
      • Hemophagocytic Lymphohistiocytoses
      • Lymphoma
      • cytokine
      • Beijing, Beijing, China
        Zhao Wang
      Oct 27, 2022

      Hemophagocytic Lymphohistiocytosis Trial in Beijing (L-DEP and PD-1 antibody)

      Not yet recruiting
      • Hemophagocytic Lymphohistiocytosis
      • L-DEP and PD-1 antibody
      • Beijing, China
        Beijing Friendship Hospital, Capital Medical University
      Apr 19, 2022

      Hemophagocytic Lymphohistiocytosis Trial in Beijing (DEP combine with PD-1 antibody)

      Recruiting
      • Hemophagocytic Lymphohistiocytosis
      • DEP combine with PD-1 antibody
      • Beijing, China
        Beijing Friendship Hospital, Capital Medical University
      Feb 13, 2022

      Primary Hemophagocytic Lymphohistiocytosis Trial in China (Emapalumab-Lzsg 5 MG/ML [Gamifant])

      Recruiting
      • Primary Hemophagocytic Lymphohistiocytosis
      • Emapalumab-Lzsg 5 MG/ML [Gamifant]
      • Shanghai, Fudan, China
      • +6 more
      Feb 23, 2023

      Toxicities in Children and Adults With Cancer

      Active, not recruiting
      • Macrophage Activation Syndrome
      • Primary Hemophagocytic Lymphohistiocytosis
        • Bethesda, Maryland
          National Cancer Institute (NCI)
        Sep 17, 2022

        Leukemia Trial in Houston (Alemtuzumab, Etoposide, Dexamethasone)

        Active, not recruiting
        • Leukemia
        • Houston, Texas
          University of Texas MD Anderson Cancer Center
        Feb 2, 2022

        Hemophagocytic Lymphohistiocytoses, Cytokine Storm Trial in Hangzhou (Dexamethasone, Etoposide, Ruxolitinib)

        Not yet recruiting
        • Hemophagocytic Lymphohistiocytoses
        • Cytokine Storm
        • Hangzhou, Zhejiang, China
          The Children's Hospital of Zhejiang University School of Medicin
        Aug 4, 2022

        Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, Acute Myeloid Leukemia Trial in Houston (iCaspase9-transduced T cells,

        Active, not recruiting
        • Acute Lymphoblastic Leukemia
        • +9 more
        • iCaspase9-transduced T cells
        • AP1903
        • Houston, Texas
        • +1 more
        Jul 22, 2022

        HLH Trial in Beijing (Zanubrutinib)

        Recruiting
        • HLH
        • Beijing, China
          Beijing Friendship Hospital, Capital Medical University
        Apr 2, 2022

        Chidamide, Hemophagocytic Lymphohistiocytosis Trial in Beijing (Chidamide combines with VP-16 and methylprednisolone)

        Recruiting
        • Chidamide
        • Hemophagocytic Lymphohistiocytosis
        • Chidamide combines with VP-16 and methylprednisolone
        • Beijing, Beijing, China
          Beijing Friendship Hospital
        Nov 29, 2021

        Adult Hemophagocytic Lymphohistiocytosis in Critically Ill

        Recruiting
        • Hemophagocytic Lymphohistiocytosis
          • Berlin, Germany
            Department of Anesthesiology and Operative Intensive Care Medici
          Jul 13, 2021